Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives
Chunhua Yang,1 Didier Merlin1,2 1Institute for Biomedical Sciences, Center for Diagnostics and Therapeutics, Digestive Disease Research Group, Georgia State University, Atlanta, GA 30302, USA; 2Atlanta Veterans Affairs Medical Center, Decatur, GA 30033, USACorrespondence: Chunhua YangInstitute for B...
Enregistré dans:
Auteurs principaux: | Yang C, Merlin D |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/95dc47a1a78b441ea911f14b7f6894be |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery
par: Naz S, et autres
Publié: (2019) -
Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy
par: Jia R, et autres
Publié: (2021) -
Peptide-Based Drug Delivery Systems
par: Dmitriy Berillo, et autres
Publié: (2021) -
Targeted delivery of doxorubicin to HER2 positive tumor models
par: Gomari H, et autres
Publié: (2019) -
Drug Delivery to the Bone Microenvironment Mediated by Exosomes: An Axiom or Enigma
par: Samal S, et autres
Publié: (2021)